PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,387,000 | +2452.1% | 539,571 | +1743.7% | 2.06% | +1663.2% |
| Q2 2016 | $407,000 | -91.2% | 29,266 | -90.4% | 0.12% | -93.0% |
| Q1 2016 | $4,634,000 | -31.3% | 305,459 | -14.1% | 1.66% | -41.2% |
| Q4 2015 | $6,743,000 | -21.8% | 355,459 | -21.7% | 2.83% | -17.0% |
| Q3 2015 | $8,624,000 | -19.4% | 453,878 | +9.3% | 3.41% | -18.2% |
| Q2 2015 | $10,703,000 | – | 415,338 | – | 4.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |